Cargando…

Combination/augmentation strategies for improving the treatment of depression

Depression is a common and debilitating condition, with considerable impact for depressed individuals and a heavy burden for society. In spite of its prevalence, depression is underrecognized and under- or inappropriately treated. In spite of the large number of antidepressants available at the pres...

Descripción completa

Detalles Bibliográficos
Autor principal: Moret, Chantal
Formato: Texto
Lenguaje:English
Publicado: Dove Medical Press 2005
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2424118/
https://www.ncbi.nlm.nih.gov/pubmed/18568111
_version_ 1782156246628958208
author Moret, Chantal
author_facet Moret, Chantal
author_sort Moret, Chantal
collection PubMed
description Depression is a common and debilitating condition, with considerable impact for depressed individuals and a heavy burden for society. In spite of its prevalence, depression is underrecognized and under- or inappropriately treated. In spite of the large number of antidepressants available at the present time, they are far from ideal and all show a similar slow, and frequently, incomplete response. Thus, the need for new and better compounds is as urgent and compelling as ever. While waiting for the panacea of future antidepressants, clinicians have developed a variety of associations of several antidepressants or an antidepressant with a second different agent. This article reviews the various strategies adopted by clinicians in the hope of increasing the response rate of current antidepressants to obtain full remission and/or to overcome treatment-resistant depression.
format Text
id pubmed-2424118
institution National Center for Biotechnology Information
language English
publishDate 2005
publisher Dove Medical Press
record_format MEDLINE/PubMed
spelling pubmed-24241182008-06-20 Combination/augmentation strategies for improving the treatment of depression Moret, Chantal Neuropsychiatr Dis Treat Review Depression is a common and debilitating condition, with considerable impact for depressed individuals and a heavy burden for society. In spite of its prevalence, depression is underrecognized and under- or inappropriately treated. In spite of the large number of antidepressants available at the present time, they are far from ideal and all show a similar slow, and frequently, incomplete response. Thus, the need for new and better compounds is as urgent and compelling as ever. While waiting for the panacea of future antidepressants, clinicians have developed a variety of associations of several antidepressants or an antidepressant with a second different agent. This article reviews the various strategies adopted by clinicians in the hope of increasing the response rate of current antidepressants to obtain full remission and/or to overcome treatment-resistant depression. Dove Medical Press 2005-12 /pmc/articles/PMC2424118/ /pubmed/18568111 Text en © 2005 Dove Medical Press Limited. All rights reserved
spellingShingle Review
Moret, Chantal
Combination/augmentation strategies for improving the treatment of depression
title Combination/augmentation strategies for improving the treatment of depression
title_full Combination/augmentation strategies for improving the treatment of depression
title_fullStr Combination/augmentation strategies for improving the treatment of depression
title_full_unstemmed Combination/augmentation strategies for improving the treatment of depression
title_short Combination/augmentation strategies for improving the treatment of depression
title_sort combination/augmentation strategies for improving the treatment of depression
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2424118/
https://www.ncbi.nlm.nih.gov/pubmed/18568111
work_keys_str_mv AT moretchantal combinationaugmentationstrategiesforimprovingthetreatmentofdepression